基本説明
Addresses key questions in therapeutic decision making.
Full Description
This book takes an innovative new approach to therapeutic decision-making, providing answers to a range of questions that the busy clinician faces on a daily basis. In a carefully chosen series of discussions, the contributors, all of whom are internationally recognised authorities in their fields, offer their own recommendations for managing difficult problems and offer insights into the value or otherwise of various treatment choices based on their own experience and the available evidence. This book addresses key questions in therapeutic decision making. The evidence-based approach highlights the factors that determine successful outcomes. It also features treatment options for specific patient groups, and presents 'what if' scenarios.
Contents
Foreword. 1. What is endothelial cell dysfunction and does it impact capacity for vasodilatation? PP Toth; 2. Sleep disorders and hypertension, CC Gonzaga, DA Calhoun; 3. Treatment of early morning surges in blood pressure, K Kario; 4. Use of out-of-office blood pressure monitoring versus office-based measurements for managing patients with hypertension, N Ghuman, WB White; 5. Is blood pressure control more important than decreasing activity in the renin-angiotensin axis? WJ Elliott; 6. Is there a class effect for all angiotensin converting enzyme inhibitors when evaluating end-organ protection? PP Toth, DA Sica; 7. Are angiotensin receptor blockers equivalent or superior to ACE inhibitors relative to blood pressure control and/or end-organ protection? RR Townsend; 8. Treatment of hypertension in the post-stroke patient in both the acute and chronic setting, WJ Elliott; 9. Isolated systolic hypertension and management of hypertension in the very elderly, SS Franklin; 10. Management of hypertension in patients with coronary artery disease, C Rosendorff; Abbreviations; General index.
